Folate status and neural tube defects

BioFactors

Volumn 10, Issue 2-3, 1999, Pages 291-294

  Molloy, Anne M ^a   Mills, James L ^b   Kirke, Peadar N ^c   Weir, Donald G ^a   Scott, John M ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c HEALTH RESEARCH BOARD   (Ireland)

Author keywords

Folate status; Methylenetetrahydrofolate reductase; Neural tube defects; Pregnancy; Red cell folates; Thermolabile MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ENZYME; FOLIC ACID;

CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; SPINA BIFIDA;

EID: 0032693097     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520100230     Document Type: Conference Paper

References (18)

1. A.E. Czeizel and I. Dudas, Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation, New England Journal of Medicine 327 (1992), 1832-1835.
2. L.E. Daly, P.N. Kirke, A.M. Molloy, D.G. Weir and J.M. Scott, Folate levels and neural tube defects: Implications for prevention, Journal of the American Medical Association 274 (1995), 1698-1702.
3. P. Frosst, H.J. Blom, R. Milos, P. Goyette, C.A. Sheppard, R.G. Matthews, G.J.H. Boers, M. den Heijer, L.A.J. Kluijtmans, L.P. van den Heuvel and R. Rosen, A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase, Nature Genetics 10 (1995), 111-113.
4. S.S. Kang, P.W.K. Wong, A. Susmano, J. Sora, M. Norusis and N. Ruggie, Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease, American Journal of Human Genetics 48 (1991), 536-545.
5. 12 are independent risk factors for neural tube defects, Quarterly Journal of Medicine 86 (1993), 703-708.
6. P.N. Kirke, J.L. Mills, A.S. Whitehead, A. Molloy and J.M. Scott, Methylenetetrahydrofolate reductase mutation and neural tube defects. Lancet 348 (1996), 1037-1038.
7. J.L. Mills, J. Tuomilehto, K.F. Yu, N. Colman, W.S. Blaner, P. Koskela, W.E. Rundle, M. Forman, L. Toivanen and G.G. Rhoads, Maternal vitamin levels during pregnancies producing infants with neural tube defects, Journal of Pediatrics 120 (1992), 863-871.
8. J.L. Mills, J.M. McPartlin, P.N. Kirke, Y.J. Lee, M.R. Conley, D.G. Weir and J.M. Scott, Homocysteine metabolism in pregnancies complicated by neural tube defects, Lancet 345 (1995), 149-151.
9. A.M. Molloy, P. Kirke, I. Hillary, D.G. Weir, J.M. Scott, Maternal serum folate and vitamin B12 concentrations in pregnancies associated with neural tube defects, Archives of Disease in Childhood 60 (1985), 660-665.
10. A.M. Molloy and J.M. Scott, Microbiological assay for serum, plasma and red cell folate using cryopreserved, microtiter plate method, Methods in Enzymology 281 (1997), 43-53.
11. A.M. Molloy, S. Daly, J.L. Mills, P.N. Kirke, A.S. Whitehead, D. Ramsbottom, M.R. Conley, D.G. Weir and J.M. Scott, Association of thermolabile variant of 5,10-methylenetetrahydrofolate reductase with low red-cell folates: Implications for folate intake recommendations, Lancet 349 (1997), 1591-1593.
12. A.M. Molloy, J.L. Mills, P.N. Kirke, D. Ramsbottom, J.M. McPartlin, H. Burke, M. Conley, A.S. Whitehead, D.G. Weir, J.M. Scott, Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10-methylenetetrahydrofolate reductase: low folate status alone may be the critical factor, American Journal of Medical Genetics 78 (1998), 155-159.
13. MRC Vitamin Study Research Group, Prevention of neural tube defects: results of the Medical Research Council Vitamin Study, Lancet 338 (1991), 131-137.
14. C.Y. Ou, R.E. Stevenson, V.K. Brown, C.E. Schwartz, W.P. Allen, M.J. Khoury, R. Rozen, G.P. Oakley, Jr. and M.J. Adams, Jr., 5,10-methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects, American Journal of Medical Genetics 63 (1996), 610-614.
15. J.A. Schneider, D.C. Rees, Y-T. Liu and J.B. Clegg, Worldwide distribution of a common methylenetetrahydrofolate reductase mutation, American Journal of Human Genetics 62 (1998), 1258-1260.
16. J. Scott and D Weir, Homocysteine and cardiovascular disease (editorial), Quarterly Journal of Medicine 89 (1996), 561-563.
17. N.M.J. van der Put, R.P.M. Steegers-Theunissen, P. Frosst, F.J.M. Trijbels, T.K.A.B. Eskes, L.P. van den Heuvel, E.C.M. Mariman, M. den Heyer, R. Rozen and H.J. Blom, Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida, Lancet 346 (1995), 1070-1071.
18. A.S. Whitehead, P. Gallagher, J.L. Mills, P.N. Kirke, H. Burke, A.M. Molloy, D.G. Weir, D.C. Shields and J.M. Scott, A genetic defect in 5,10-methylenetetrahydrofolate reductase in neural tube defects, Quarterly Journal of Medicine 88 (1995), 763-766.